Invicro, a Konica Minolta Company focused on imaging for translational drug discovery and development, has appointed Matthew Silva as CEO. Silva, who will also join Invicro's board, joined the company in 2012 and was most recently executive vice president of scientific applications. He has also worked in leadership positions at Vertex, Amgen, Millenium, and Takeda Pharmaceuticals.
Silva will replace Jack Hoppin as Invicro's CEO. Hoppin is a cofounder of the company and will move from his role as Invicro CEO to be the president of Konica Minolta Precision Medicine. Hoppin will also serve on the boards of both companies.